|
|
Volumn 11, Issue 9, 2012, Pages 664-
|
|
Regulatory watch: Pioneering gene therapy on brink of approval
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOVIRUS VECTOR;
ALIPOGENE TIPARVOVEC;
BLOOD CLOTTING FACTOR 9;
LIPOPROTEIN LIPASE;
AUTOSOMAL RECESSIVE DISORDER;
DRUG APPROVAL;
DRUG SAFETY;
GENE EXPRESSION;
HEMOPHILIA B;
HUMAN;
HYPERLIPOPROTEINEMIA TYPE 1;
INCIDENCE;
MUTAGENESIS;
NOTE;
PANCREATITIS;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
TRANSGENE;
VIRAL GENE THERAPY;
DRUG APPROVAL;
EUROPE;
GENE THERAPY;
GENETIC VECTORS;
HUMANS;
LIPOPROTEIN LIPASE;
|
|
EID: 84866080241
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3835 Document Type: Note |
|
Times cited : (19)
|
|
References (0)
|
